These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37795908)

  • 1. Blood-Based Biomarkers for HCC Surveillance: Ready for the Center Stage?
    Singal AG; Yang JD; Parikh ND
    Am J Gastroenterol; 2023 Oct; ():. PubMed ID: 37795908
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of HCC surveillance programs using multitarget blood test: A modeling study.
    Chhatwal J; Samur S; Yang JD; Roberts LR; Nguyen MH; Ozbay AB; Ayer T; Parikh ND; Singal AG
    Hepatol Commun; 2023 Jun; 7(6):. PubMed ID: 37204402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal surveillance program for hepatocellular carcinoma - getting ready, but not yet.
    Wong GL
    World J Hepatol; 2015 Aug; 7(18):2133-5. PubMed ID: 26328024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review.
    Shahini E; Pasculli G; Solimando AG; Tiribelli C; Cozzolongo R; Giannelli G
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Blood-Based Panel of Methylated DNA and Protein Markers for Detection of Early-Stage Hepatocellular Carcinoma.
    Chalasani NP; Ramasubramanian TS; Bhattacharya A; Olson MC; Edwards V DK; Roberts LR; Kisiel JB; Reddy KR; Lidgard GP; Johnson SC; Bruinsma JJ
    Clin Gastroenterol Hepatol; 2021 Dec; 19(12):2597-2605.e4. PubMed ID: 32889146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a Novel Multitarget Blood Test Shows High Sensitivity to Detect Early Stage Hepatocellular Carcinoma.
    Chalasani NP; Porter K; Bhattacharya A; Book AJ; Neis BM; Xiong KM; Ramasubramanian TS; Edwards DK; Chen I; Johnson S; Roberts LR; Kisiel JB; Reddy KR; Singal AG; Olson MC; Bruinsma JJ
    Clin Gastroenterol Hepatol; 2022 Jan; 20(1):173-182.e7. PubMed ID: 34391922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers: evaluation of clinical utility in surveillance and early diagnosis for hepatocellular carcinoma.
    Song P; Tang Q; Feng X; Tang W
    Scand J Clin Lab Invest Suppl; 2016; 245():S70-6. PubMed ID: 27438343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma cell free DNA methylation markers for hepatocellular carcinoma surveillance in patients with cirrhosis: a case control study.
    Lewin J; Kottwitz D; Aoyama J; deVos T; Garces J; Hasinger O; Kasielke S; Knaust F; Rathi P; Rausch S; Weiss G; Zipprich A; Mena E; Fong TL
    BMC Gastroenterol; 2021 Mar; 21(1):136. PubMed ID: 33765926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early detection of hepatocellular carcinoma: roadmap for improvement.
    Melendez-Torres J; Singal AG
    Expert Rev Anticancer Ther; 2022 Jun; 22(6):621-632. PubMed ID: 35514249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of serological tumor biomarkers for surveillance of hepatocellular carcinoma in patients undergoing dialysis.
    Toyoda H; Kikuchi K; Tsuruta Y; Hiraoka A; Tsuji K; Tanaka J
    Nephrol Dial Transplant; 2021 May; 36(6):1097-1103. PubMed ID: 33009910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial.
    An C; Kim DY; Choi JY; Han KH; Roh YH; Kim MJ
    BMC Cancer; 2018 Sep; 18(1):915. PubMed ID: 30249190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute-phase serum amyloid A for early detection of hepatocellular carcinoma in cirrhotic patients with low AFP level.
    Wu JL; Su TH; Chen PJ; Chen YR
    Sci Rep; 2022 Apr; 12(1):5799. PubMed ID: 35388082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A National Survey of Hepatocellular Carcinoma Surveillance Practices Following Liver Transplantation.
    Aggarwal A; Te HS; Verna EC; Desai AP
    Transplant Direct; 2021 Jan; 7(1):e638. PubMed ID: 33324743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individualized surveillance of chronic hepatitis B patients according to hepatocellular carcinoma risk based on PAGE-B scores.
    Kim JH; Kang SH; Lee M; Choi HS; Jun BG; Kim TS; Choi DH; Suk KT; Kim MY; Kim YD; Cheon GJ; Baik SK; Kim DJ
    Eur J Gastroenterol Hepatol; 2021 Dec; 33(12):1564-1572. PubMed ID: 32804840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Role of Molecular and Imaging Biomarkers for Predicting Advanced Hepatocellular Carcinoma Treatment Efficacy.
    Cerrito L; Ainora ME; Mosoni C; Borriello R; Gasbarrini A; Zocco MA
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current biomarkers for hepatocellular carcinoma: Surveillance, diagnosis and prediction of prognosis.
    Schütte K; Schulz C; Link A; Malfertheiner P
    World J Hepatol; 2015 Feb; 7(2):139-49. PubMed ID: 25729470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimarker Panels for Detection of Early Stage Hepatocellular Carcinoma: A Prospective, Multicenter, Case-Control Study.
    Piratvisuth T; Tanwandee T; Thongsawat S; Sukeepaisarnjaroen W; Esteban JI; Bes M; Köhler B; He Y; Swiatek-de Lange M; Morgenstern D; Chan HL
    Hepatol Commun; 2022 Apr; 6(4):679-691. PubMed ID: 34796691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The alpha-fetoprotein serum is still reliable as a biomarker for the surveillance of hepatocellular carcinoma in Indonesia.
    Jasirwan COM; Fahira A; Siregar L; Loho I
    BMC Gastroenterol; 2020 Jul; 20(1):215. PubMed ID: 32646378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease.
    Beale G; Chattopadhyay D; Gray J; Stewart S; Hudson M; Day C; Trerotoli P; Giannelli G; Manas D; Reeves H
    BMC Cancer; 2008 Jul; 8():200. PubMed ID: 18638391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular Carcinoma Surveillance: Evidence-Based Tailored Approach.
    Koo E; Singal AG
    Surg Oncol Clin N Am; 2024 Jan; 33(1):13-28. PubMed ID: 37945138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.